We examined the expression patterns of several RTKs (c-Kit, c-Met, AXL, HER-1, HER-2, and IGF-1R) in GIST patients by IHC to identify therapeutic opportunities that may help prevent and/or overcome drug resistance. The gene discussed is MET; the disease is gastrointestinal stromal tumor.